Nicolas Fulpius - 18 Mar 2026 Form 3 Insider Report for InflaRx N.V. (IFRX)

Role
Director
Signature
/s/ Christian Schmid, Attorney-in-Fact
Issuer symbol
IFRX
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:07:33 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fulpius Nicolas Director C/O INFLARX N.V., WINZERLAER STREET 2, JENA, GERMANY /s/ Christian Schmid, Attorney-in-Fact 18 Mar 2026 0002115848

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IFRX Ordinary Shares 490,052 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 34,464 $1.86 Direct F1
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 30,000 $1.86 Direct F2
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 9,601 $1.86 Direct F3
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 45,000 $1.86 Direct F4
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 45,000 $2.37 Direct F5
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 45,000 $1.79 Direct F6
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 45,000 $2.41 Direct F7
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 45,000 $1.17 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 13, 2017 and is fully vested and exercisable as of the date hereof.
F2 This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof.
F3 This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.
F4 This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.
F5 This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.
F6 This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.
F7 This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.
F8 This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 11,250 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney